Alex A. Adjei, MD, PhD | Authors

Gemcitabine and Pemetrexed Disodium in Treating Breast Cancer

February 01, 2001

Pemetrexed disodium (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase. This agent is broadly active in a wide

Pharmacology and Clinical Status of Capecitabine

September 01, 2000

In this issue of Oncology, Dr. Schilsky has provided a comprehensive yet concise review of the pharmacology of the fluoropyrimidines and, in particular, capecitabine (Xeloda).